Fluoroquinolones vs amoxicillinSerious adverse events · adults aged 18 years and above with diagnosis of non‐cystic fibrosis bronchiectasis1 finding from 1 reviewHead‐to‐head trials of antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 83 participantsLow